Balxap Trademark Details

This mark is dead with a status of Abandoned - After Publication. The last case file activity for this mark occured 15 years ago on Monday, September 22, 2008, according to the United State Patent & Trademark Office
Word Mark Balxap
Status Dead 605 — Abandoned - After Publication

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 77283021
Status Date Monday, September 22, 2008
Filing Date Monday, September 22, 2008
Attorney Nadine P. Flynn

Correspondent

NADINE P. FLYNN
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVE
NEW YORK, NY 10154-0004

Case File Statements

Goods & Services Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Translation of Words in Mark The wording "BALXAP" has no meaning in a foreign language.

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 8 — Abandoned
Status Date Monday, September 22, 2008
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.